High-level expression and novel purification strategy of recombinant thanatin analog in Escherichia coli

Current Microbiology

Volumn 57, Issue 2, 2008, Pages 95-101

  Wu, G Q ^a   Li, L X ^b   Ding, J X ^b   Wen, L Z ^b   Shen, Z L ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HYBRID PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; RECOMBINANT THANATIN;

AMINO TERMINAL SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CONTROLLED STUDY; ENZYME ASSAY; ESCHERICHIA COLI; GENE SEQUENCE; HEATING; KLEBSIELLA PNEUMONIAE; NONHUMAN; PH MEASUREMENT; PLASMID; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL CATIONIC PEPTIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; PLASMIDS; RECOMBINANT FUSION PROTEINS;

ESCHERICHIA COLI;

EID: 46749097855     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-008-9106-z     Document Type: Article

References (22)

1. Hancock REW, Diamond G (2000) The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8:402-410
2. Wang Z, Wang G (2004) APD: the antimicrobial peptide database. Nucleic Acids Res 32:D590-D592
3. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395
4. Yang D, Biragyn A, Hoover DM et al (2002) Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 23:291-296
5. Fehlbaum P, Bulet P, Chemysh S et al (1996) Structure activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci USA 93:1221-1225
6. Myung KL, Lina C, Si HL et al (2001) Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. J Biochem Mol Biol 35:291-296
7. Makrides SC (1996) Strategies for achieving high level expression of genes in Escherichia coli. Microbiol Rev 60:512-538
8. Piers KL, Brown MH, Hancock REW (1993) Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134:7-13
9. Lavallie ER, DiBlasio EA, Kovacic S et al (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology 11:187-193
10. Horton RM, Cai ZL, Ho SN et al (1990) Gene splicing by overlap extension: Tailor made genes using the polymerase chain reaction. Biotechniques 8:528-535
11. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory, New York
12. Wu G, Bashir Bello N, Freeland SJ (2005) The synthetic gene designer: A flexible web platform to explore sequence manipulation for heterologous expression. Protein Expr Purif 47:441-415
13. Bradford MM (1976) A rapid and sensitive method for the quantitation of protein utilizing the principles of protein-dye binding. Anal Biochem 72:248-254
14. Huili Lu, Mei Yu, Ye Sun et al (2007) Expression and purification of bioactive high purity mouse monokine induced by IFN in Escherichia coli. Protein Expr Purif 55:132-138
15. Donovan RS, CW Robinson BR Glick (1996) Review: optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J Ind Microbiol 16:145-154
16. Catherine H. Schein, Mathieu H, Noteborn M (1988) Formation of soluble recombinant proteins in Escherichia coli is favored by lower growth temperature. Biotechnology 6:291-294
17. Horiuchi J, Kamasawa M, Miyakawa H et al (1994) Effects of pH on expression and stabilization of galactosidase by recombinant E. coli with a thermally-inducible expression system. Biotechnol Lett 16:113-118
18. Anderson RC, Yu P-L (2005) Factors affecting the antimicrobial activity of ovine-derived cathelicidins against E. coli 0157:H7. Int J Antimicrob Agents 25:205-210
19. Ponti D, Mignogna G, Mangoni ML et al (1999) Expression and activity of cyclic and linear analogues of esculentin-1, an antimicrobial peptide from amphibian skin. Eur J Biochem 263:921-927
20. Kelly WS (1996) Therapeutic peptides: the devil is in the details. Biotechnology 14:28-31
21. Maldonado LMTP, Hernandez VEB, Rivero EM et al (2007) Optimization of culture conditions for a synthetic gene expression in Escherichia coli using response surface methodology: the case of human interferon beta. Biomol Eng 24:217-222
22. Stellwagen E (1990) Gel filtration. Methods Enzymol 182:317-328